Changchun BCHT Biotechnology Co. (688276.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Changchun BCHT Biotechnology Co.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1241
First IPO Date
June 25, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Chunlai Jiang | GM & Director | 0 | 1973 |
| Dawei Liu | Deputy General Manager | 0 | 1972 |
| Zhaofeng Meng | Chief Financial Officer | 0 | 1964 |
| Zhe Zhang | Board Secretary | 0 | 1976 |
| Fu Qiang Yan | Accounting Supervisor | 0 | N/A |
| Changlin Zhu | Secretary of the Party Branch, Chairman of the Trade Union, & Chief Engineer of BaiKe Biotechnology | 0 | 1969 |
| Xiaohui Chen | Chief Operating Specialist | 0 | N/A |
| Zang Yang | Executive Vice President of the Institute of Drug Research | 0 | N/A |
| Wei Wei | Deputy General Manager | 0 | 1970 |
AD
Description
Changchun BCHT Biotechnology Co. Ltd. is a biopharmaceutical enterprise primarily focused on the research, development, production, and global commercialization of vaccines designed for human use. Its extensive product portfolio features key immunizations such as attenuated (live) herpes zoster and varicella vaccines, alongside a live, nasal, and freeze-dried influenza vaccine, and a rabies vaccine utilizing vero cell technology. This company was established in 2004 and is headquartered in Changchun, China.
AD
